BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11694096)

  • 1. Animal models of zygomycosis--Absidia, Rhizopus, Rhizomucor, and Cunninghamella.
    Kamei K
    Mycopathologia; 2001; 152(1):5-13. PubMed ID: 11694096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cerebral zygomycosis in alloxan-diabetic rabbits: variation in virulence among zygomycetes.
    Reinhardt DJ; Licata I; Kaplan W; Ajello L; Chandler FW; Ellis JJ
    Sabouraudia; 1981 Dec; 19(4):245-56. PubMed ID: 6798698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zygomycosis.
    Freifeld AG; Iwen PC
    Semin Respir Crit Care Med; 2004 Apr; 25(2):221-31. PubMed ID: 16088464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreaks of zygomycosis in hospitals.
    Antoniadou A
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():55-9. PubMed ID: 19754759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of zygomycete species identified in clinically significant specimens in the United States.
    Alvarez E; Sutton DA; Cano J; Fothergill AW; Stchigel A; Rinaldi MG; Guarro J
    J Clin Microbiol; 2009 Jun; 47(6):1650-6. PubMed ID: 19386856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zygomycetes in human disease.
    Ribes JA; Vanover-Sams CL; Baker DJ
    Clin Microbiol Rev; 2000 Apr; 13(2):236-301. PubMed ID: 10756000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis.
    Dannaoui E; Mouton JW; Meis JF; Verweij PE;
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1953-9. PubMed ID: 12019114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Zygomycosis: review of 16 cases].
    González A; del Palacio A; Cuétara MS; Gómez C; Carabias E; Malo Q
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):233-9. PubMed ID: 9044638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.
    Hsieh TT; Tseng HK; Sun PL; Wu YH; Chen GS
    Mycopathologia; 2013 Feb; 175(1-2):99-106. PubMed ID: 23124364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 7: zygomycosis.
    Severo CB; Guazzelli LS; Severo LC
    J Bras Pneumol; 2010; 36(1):134-41. PubMed ID: 20209316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of posaconazole in treatment of experimental disseminated zygomycosis.
    Dannaoui E; Meis JF; Loebenberg D; Verweij PE
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3647-50. PubMed ID: 14576138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental cerebral zygomycosis in alloxan-diabetic rabbits I. Relationship of temperature tolerance of selected zygomycetes to pathogenicity.
    Reinhardt DJ; Kaplan W; Ajello L
    Infect Immun; 1970 Oct; 2(4):404-13. PubMed ID: 16557853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zygomycosis--a case report and overview of the disease in India.
    Diwakar A; Dewan RK; Chowdhary A; Randhawa HS; Khanna G; Gaur SN
    Mycoses; 2007 Jul; 50(4):247-54. PubMed ID: 17576314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes.
    Gil-Lamaignere C; Simitsopoulou M; Roilides E; Maloukou A; Winn RM; Walsh TJ
    J Infect Dis; 2005 Apr; 191(7):1180-7. PubMed ID: 15747255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zygomycosis presenting a major clinical challenge: case report on Rhizomucor pusillus infection in a stem-cell-transplant recipient.
    Kivivuori SM; Karikoski R; Koukila-Kähkölä P; Anttila VJ; Saarinen-Pihkala UM
    Mycopathologia; 2011 Sep; 172(3):241-5. PubMed ID: 21475989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical identification of aetiological agents of systemic bovine zygomycosis.
    Jensen HE; Aalbaek B; Schønheyder H
    J Comp Pathol; 1994 Jan; 110(1):65-77. PubMed ID: 8040374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
    Narreddy S; Manavathu E; Chandrasekar PH; Alangaden GJ; Revankar SG
    J Antimicrob Chemother; 2010 Apr; 65(4):701-3. PubMed ID: 20130026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous disease.
    Dekkers R; Verweij PE; Weemaes CM; Severijnen RS; Van Krieken JH; Warris A
    Med Mycol; 2008 Aug; 46(5):491-4. PubMed ID: 18608916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
    J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of an immunodiffusion test for diagnosis of systemic zygomycosis (mucormycosis): preliminary report.
    Jones KW; Kaufman L
    J Clin Microbiol; 1978 Jan; 7(1):97-103. PubMed ID: 75212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.